Night-to-Night Swings in Sleep Apnea Predict Heart Risk — Not Just the Average

 

Recent large-scale home-monitoring studies from Flinders University show that variability in obstructive sleep apnea (OSA) severity across nights is a stronger marker of cardiovascular risk and vascular ageing than average nightly severity alone. People with high night‑to‑night swings had ~30–35% greater odds of prior myocardial infarction, stroke, or heart failure, and even individuals with mild average OSA but large variability exhibited vascular‑health measures similar to those with persistently severe OSA. The authors recommend multi‑night monitoring for better risk detection and earlier intervention.

Background

• Traditional OSA assessment relies on a single-night polysomnography or home sleep apnea test, reporting average indices such as AHI (apnea–hypopnea index).
• Sleep and breathing vary night to night due to position, alcohol, nasal congestion, sleep stage distribution, weight change, and intermittent adherence to therapies.
• Repeated oxygen desaturations and sleep fragmentation are biologically plausible drivers of cardiovascular harm.

Methods (summary of approach)

• Large observational cohorts monitored at home for months to years using contactless under‑mattress sensors that estimate nightly respiratory disturbance indices and sleep metrics.
• Analyses included thousands to tens of thousands of adults, calculating per-person summary measures: mean severity, standard deviation (night‑to‑night variability), and metrics of vascular health (e.g., measures of vascular ageing and clinical cardiovascular outcomes).
• Statistical models adjusted for typical confounders (age, sex, BMI, comorbidities, average OSA severity) to isolate the association of variability with cardiovascular outcomes.

Key findings

• Night‑to‑night variability in OSA severity was independently associated with a ~30–35% higher likelihood of prior major cardiovascular events (myocardial infarction, stroke, heart failure) compared with low-variability peers, even after adjusting for mean OSA severity and other covariates.
• Individuals with low mean AHI but high variability showed vascular‑health profiles comparable to those with persistently high mean AHI.
• Variability measures added prognostic information beyond single‑night measures; a single-night test missed a substantial subset of people with clinically relevant intermittent severe disease.
• Authors emphasize the physiologic plausibility: repeated swings in oxygenation and recurrent sleep disruption may impart cumulative vascular stress beyond that predicted by average indices.

Interpretation and clinical implications

• Clinical risk stratification that relies solely on one-night testing can underdetect people at elevated cardiovascular risk due to intermittent severe OSA.
• Multi‑night monitoring (analogous to ambulatory blood pressure or continuous glucose monitoring) can identify patients with high variability who may benefit from early intervention, closer follow‑up, or therapeutic trials.
• Practical approaches include multi‑night home testing, use of long‑term noncontact sensors, or repeated short home studies; clinicians should consider variability when interpreting mild or borderline single-night results.
• Causality is not established: observational associations support plausible mechanisms, but randomized trials would be needed to show that treating intermittent/severe nights reduces cardiovascular events.

Limitations noted by the studies

• Observational design — cannot prove treatment of variability prevents events.
• Under‑mattress devices estimate respiratory events (not full polysomnography); device validation and measurement error are relevant.
• Cohort composition, selection bias, and residual confounding may influence effect size.
• Outcomes largely cross‑sectional or retrospective associations with prior events in some analyses; prospective outcome data remain limited.

Recommendations (practical)

• For clinicians: consider multi‑night assessment for patients with symptoms but a normal or mild single-night study, and incorporate variability when estimating risk.
• For researchers: prospective studies and trials should test whether identifying/treating high-variability OSA reduces cardiovascular events.
• For health systems: evaluate feasibility of scalable multi‑night home monitoring (devices, algorithms, data pathways) and reimbursement models.

Conclusion

Large home-monitoring studies indicate that night‑to‑night variability in OSA severity is a clinically meaningful marker of cardiovascular risk that can be missed by single‑night testing. Multi‑night assessment could improve early detection and targeting of interventions, though prospective trials are needed to confirm that addressing variability reduces hard cardiovascular outcomes.

Citations

• Lechat B., et al. (2026). Night-to-night variability in obstructive sleep apnea and cardiovascular outcomes. SLEEP.
• Lechat B., et al. (2026). Multi‑night home monitoring of sleep-disordered breathing and vascular ageing. npj Digital Medicine.